Clinical Trials List
2025-06-06 - 2028-09-13
Phase III
Recruiting7
ICD-10C50.011
Malignant neoplasm of nipple and areola, right female breast
ICD-10C50.012
Malignant neoplasm of nipple and areola, left female breast
ICD-10C50.019
Malignant neoplasm of nipple and areola, unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- Shang-Hung Chen Division of General Surgery
- Wei-Pang Chung Division of General Surgery
- 黃怡菁 Division of General Surgery
- 魏慈慧 Division of General Surgery
- Jui-Hung Tsai Division of General Surgery
- 黃怡璇 Division of General Surgery
- Chun-Hui Lee Division of General Surgery
- 楊舜如 Division of General Surgery
- Zhu-Jun Loh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING-YANG WANG Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
- 陳怡君
- 李佳真 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- 林柏翰 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 羅喬 Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊博雅 Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
- 蘇智銘 Division of Hematology & Oncology
- 廖立民 Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- KA-WAI TAM Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jung Chen Division of General Surgery
- HWEI-CHUNG WANG Division of General Surgery
- 黃至豪 Division of General Surgery
- Yao-Chung Wu Division of General Surgery
- Chen-Teng Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 巫承哲 Division of General Surgery
- 高理鈞 Division of General Surgery
- Chung-Liang Li Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Fang-Ming Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ta-Chung Chao Division of General Surgery
- 賴亦貞 Division of General Surgery
- 林燕淑 Division of General Surgery
- Chun-Yu Liu Division of General Surgery
- Jiun-I Lai Division of General Surgery
- 陳彥蓁 Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- 鄭涵方 Division of General Surgery
- 邱仁輝 Division of General Surgery
- 馮晉榮 Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
674 participants
